Apport de la visite d’assistants de recherche clinique aux cabinets de médecins généralistes sur la notification des effets indésirables médicamenteux-Reference-Cited by-同舟云学术

Apport de la visite d’assistants de recherche clinique aux cabinets de médecins généralistes sur la notification des effets indésirables médicamenteux

Published:2017-06 Issue:3 Volume:72 Page:351-355
ISSN:0040-5957
Container-title:Therapies
language:fr
Short-container-title:Therapies

Author:

Durrieu Geneviève,Jacquot Julien,Baudrin Dominique,Mège Mathilde,Rousseau Vanessa,Bagheri Haleh,Bondon-Guitton Emmanuelle,Abadie Delphine,Montastruc François,Bismuth Michel,Oustric Stéphane,Montastruc Jean-Louis

Publisher

Elsevier BV

Subject

Pharmacology (medical)

Reference21 articles.

1. The nature of the scientific evidence leading to drug withdrawals for pharmacovigilance reasons in France;Olivier;Pharmacoepidemiol Drug Saf,2006

2. French pharmacovigilance: missions, organization and perspectives;Vial;Therapie,2016

3. Nouvelles méthodes d’étude du risque médicamenteux : l’expérience du Centre Midi-Pyrénées de Pharmacovigilance;Montastruc;Bull Acad Natl Med,2005

4. Under-reporting of adverse drug reactions: a systematic review;Hazell;Dug Saf,2006

5. Attitudinal survey of voluntary reporting of adverse drug reactions;Eland;Br J Clin Pharmacol,1999

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluation of a simplified pharmacovigilance tool for general practitioners: 5 years of insight;Scientific Reports;2024-01-20

2. Cabinets de médecine générale et notification des effets indésirables médicamenteux : expertise d’un délégué de l’Assurance maladie;Santé Publique;2023-03-28

3. Regulating pediatric off-label uses of medicines in the EU and USA: challenges and potential solutions;International Journal of Clinical Pharmacy;2021-09-08

4. Interest of a general practitioner pharmacovigilance network to provide drug information: A comparative study in France;Therapies;2020-11

5. Interventions to improve adverse drug reaction reporting: A scoping review;Pharmacoepidemiology and Drug Safety;2020-05-19